PMID- 8825559 OWN - NLM STAT- MEDLINE DCOM- 19961204 LR - 20081121 IS - 0888-8809 (Print) IS - 0888-8809 (Linking) VI - 10 IP - 2 DP - 1996 Feb TI - Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor. PG - 196-205 AB - Transcriptional and DNA binding activities of the human vitamin D receptor (hVDR) were examined in the yeast Saccharomyces cerevisiae. In the studies described here, VDR itself exhibited little transcriptional activity regardless of the nature of the vitamin D-responsive elements (VDREs) used. Consistent with its lack of functional activity, recombinant VDR was unable to bind to VDREs in vitro using bandshift analysis. Interestingly, VDR was able to bind to VDREs with high affinity and to fully activate transcription in intact yeast cells in the presence of the retinoid X receptor (RXR). Although RXR subtypes displayed a similar capacity to induce heterodimer formation with VDR on VDREs, RXR gamma was the strongest of the subtypes in potentiating VDR-dependent transactivation. We also evaluated both DNA binding and transcriptional activities of VDR alone and VDR plus RXR on directly repeated response elements whose half-sites were separated by three and six base pairs. DNA-binding assays together with functional assays revealed that VDR was active only in the presence of RXR, regardless of spacing. Using a domain-swap approach, we constructed a chimeric receptor in which the DNA-binding domain of VDR was replaced with that of the glucocorticoid receptor. Interaction of both wild type and chimeric receptors with a hybrid-responsive element in the presence of RXR revealed that RXR and VDR bound to the 5'- and 3'-half-sites of VDRE, respectively. Finally, we show that the fifth position in the 3'-half-site (C) of the VDRE strongly influences the binding of VDR/RXR heterodimer to its cognate cis-elements. Cumulatively, our studies demonstrate, using an eukaryotic yeast system, that the functional VDR unit includes RXR or an equal partner. FAU - Jin, C H AU - Jin CH AD - Department of Skeletal Biology, Ligand Pharmaceuticals Inc., San Diego, California 92121, USA. FAU - Pike, J W AU - Pike JW LA - eng PT - Journal Article PL - United States TA - Mol Endocrinol JT - Molecular endocrinology (Baltimore, Md.) JID - 8801431 RN - 0 (DNA-Binding Proteins) RN - 0 (Receptors, Calcitriol) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Retinoid X Receptors) RN - 0 (Transcription Factors) SB - IM MH - Base Sequence MH - DNA-Binding Proteins/*genetics MH - Humans MH - Molecular Sequence Data MH - Receptors, Calcitriol/biosynthesis/*genetics MH - Receptors, Retinoic Acid/*genetics MH - Retinoid X Receptors MH - Saccharomyces cerevisiae/*genetics MH - Signal Transduction MH - Transcription Factors/*genetics MH - *Transcriptional Activation EDAT- 1996/02/01 00:00 MHDA- 1996/02/01 00:01 CRDT- 1996/02/01 00:00 PHST- 1996/02/01 00:00 [pubmed] PHST- 1996/02/01 00:01 [medline] PHST- 1996/02/01 00:00 [entrez] AID - 10.1210/mend.10.2.8825559 [doi] PST - ppublish SO - Mol Endocrinol. 1996 Feb;10(2):196-205. doi: 10.1210/mend.10.2.8825559.